Knowledge and attitudes about hepatitis C virus (HCV) infection and its treatment in HCV mono-infected and HCV/HIV co-infected adults

Journal of Viral Hepatitis

Volumn 20, Issue 10, 2013, Pages 708-714

  Chen, E Y ^a   North, C S ^a   Fatunde, O ^a   Bernstein, I ^b   Salari, S ^a   Day, B ^a   Jain, M K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

attitude; health beliefs; hepatitis C virus; human immunodeficiency virus; intervention research; knowledge

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HEALTH BEHAVIOR; HEALTH BELIEF; HEALTH SURVEY; HELP SEEKING BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; SCORING SYSTEM; SHAME; TREATMENT INDICATION; VIRUS STRAIN;

ATTITUDE; HEALTH BELIEFS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INTERVENTION RESEARCH; KNOWLEDGE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 84884139577     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12095     Document Type: Article

References (29)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ,. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144 (10): 705-714.
2. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F,. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008; 47 (4): 1128-1135.
3. Bacon BR, Gordon SC, Lawitz E, et al,. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364 (13): 1207-1217.
4. Jacobson IM, McHutchison JG, Dusheiko G, et al,. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364 (25): 2405-2416.
5. Poordad F, McCone J Jr, Bacon BR, et al,. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364 (13): 1195-1206.
6. Zeuzem S, Andreone P, Pol S, et al,. Telaprevir for retreatment of HCV infection. N Engl J Med 2011; 364 (25): 2417-2428.
7. Innes HA, Hutchinson SJ, Allen S, et al,. Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care. Hepatology 2011; 54 (5): 1547-1558.
8. Shiratori Y, Ito Y, Yokosuka O, et al,. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med 2005; 142 (2): 105-114.
9. Veldt BJ, Heathcote EJ, Wedemeyer H, et al,. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007; 147 (10): 677-684.
10. Vezali E, Aghemo A, Colombo M,. A review of the treatment of chronic hepatitis C virus infection in cirrhosis. Clin Ther 2010; 32 (13): 2117-2138.
11. Berenguer J, Alvarez-Pellicer J, Martin PM, et al,. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50 (2): 407-413.
12. Joshi D, O'Grady J, Dieterich D, Gazzard B, Agarwal K,. Increasing burden of liver disease in patients with HIV infection. Lancet 2011; 377 (9772): 1198-1209.
13. Volk ML, Tocco R, Saini S, Lok AS,. Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology 2009; 50 (6): 1750-1755.
14. Zacks S, Beavers K, Theodore D, et al,. Social stigmatization and hepatitis C virus infection. J Clin Gastroenterol 2006; 40 (3): 220-224.
15. Fisher JD, Amico KR, Fisher WA, Harman JJ,. The information-motivation- behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep 2008; 5 (4): 193-203.
16. Beer L, Fagan JL, Valverde E, Bertolli J, Never in Care Project. Health-related beliefs and decisions about accessing HIV medical care among HIV-infected persons who are not receiving care. AIDS Patient Care STDS 2009; 23 (9): 785-792.
17. Gardner LI, Marks G, Metsch LR, et al,. Psychological and behavioral correlates of entering care for HIV infection: the Antiretroviral Treatment Access Study (ARTAS). AIDS Patient Care STDS 2007; 21 (6): 418-425.
18. Carey MP, Morrison-Beedy D, Johnson BT,. The HIV-knowledge questionnaire: development and evaluation of a reliable, valid, and practical self-administered questionnaire. AIDS Behav 1997; 1 (1): 61-74.
19. Grebely J, Genoway KA, Raffa JD, et al,. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend 2008; 2: 141-147.
20. Evon DM, Simpson KM, Esserman D, Verma A, Smith S, Fried MW,. Barriers to accessing care in patients with chronic hepatitis C: the impact of depression. Aliment Pharmacol Ther 2010; 32 (9): 1163-1173.
21. Swan D, Long J, Carr O, et al,. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS Patient Care STDS 2010; 24 (12): 753-762.
22. McGowan CE, Fried MW,. Barriers to hepatitis C treatment. Liver Int 2012; 32 (Suppl. 1): 151-156.
23. Kalichman SC, Rompa D, DiFonzo K, et al,. HIV treatment adherence in women living with HIV/AIDS: research based on the Information-Motivation- Behavioral Skills model of health behavior. J Assoc Nurses AIDS Care 2001; 12 (4): 58-67.
24. Braitstein P, Li K, Kerr T, Montaner JS, Hogg RS, Wood E,. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone. AIDS Care 2006; 18 (7): 690-693.
25. Lekas HM, Siegel K, Leider J,. Felt and enacted stigma among HIV/HCV-coinfected adults: the impact of stigma layering. Qual Health Res 2011; 21 (9): 1205-1219.
26. Fultz SL, Justice AC, Butt AA, et al,. Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clin Infect Dis 2003; 8: 1039-1046.
27. Nunes D, Saitz R, Libman H, Cheng DM, Vidaver J, Samet JH,. Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems. Alcohol Clin Exp Res 2006; 30 (9): 1520-1526.
28. Gupta K, Romney D, Briggs M, Benker K,. Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals. J Community Health 2007; 32 (4): 221-230.
29. Proeschold-Bell RJ, Hoeppner B, Taylor B, et al,. An interrupted time series evaluation of a hepatitis C intervention for persons with HIV. AIDS Behav 2011; 15 (8): 1721-1731.